13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 70 holding rows worth $415,499,000.
- Accession
- 0001387131-17-000789
- Filer
- CIK 1595851
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 70 entries on the cover page, a total value of $415,499,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $415,499,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 600,000 | $35,514,000 | thousands by filing date | put |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 100,000 | $17,038,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 400,000 | $15,364,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 115,000 | $14,070,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 130,000 | $13,416,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 225,000 | $13,246,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 110,000 | $12,733,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 325,000 | $11,417,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 200,000 | $10,212,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 150,000 | $10,104,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 350,000 | $10,094,000 | thousands by filing date | call |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 220,000 | $9,772,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 450,000 | $9,734,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 150,000 | $8,766,000 | thousands by filing date | call |
| AVEXIS INC | 05366U100 | COM | 175,000 | $8,353,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 335,000 | $8,208,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 150,000 | $7,916,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 200,000 | $7,682,000 | thousands by filing date | call |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 70,000 | $7,606,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 330,000 | $7,326,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,150,000 | $7,280,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 200,000 | $6,860,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 975,000 | $6,776,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 135,000 | $6,726,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 175,000 | $6,624,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 90,000 | $6,539,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 300,000 | $6,489,000 | thousands by filing date | call |
| IMMUNOMEDICS INC | 452907108 | COM | 1,700,000 | $6,239,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 200,000 | $6,140,000 | thousands by filing date | call |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 575,000 | $5,974,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 100,000 | $5,844,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 140,000 | $5,842,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 70,000 | $5,826,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 475,000 | $5,748,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 250,000 | $5,575,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 200,000 | $5,486,000 | thousands by filing date | call |
| CURRENCYSHARES SWISS FRANC TRU | 23129V109 | ETF | 46,400 | $4,349,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 15,000 | $4,254,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 250,000 | $4,118,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 365,000 | $4,052,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 175,000 | $4,022,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 80,000 | $3,992,000 | thousands by filing date | |
| ENTELLUS MED INC | 29363K105 | COM | 200,000 | $3,794,000 | thousands by filing date | |
| QIAGEN NV | N72482107 | COMMON STOCK-FO | 135,000 | $3,783,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 225,000 | $3,715,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 115,182 | $3,455,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 120,000 | $3,257,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 100,000 | $2,884,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 200,000 | $2,812,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 225,000 | $2,734,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 75,000 | $2,546,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 325,000 | $2,503,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 17,000 | $2,286,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 129,100 | $2,089,000 | thousands by filing date | call |
| BLUEBIRD BIO INC | 09609G100 | COM | 30,000 | $1,851,000 | thousands by filing date | |
| Rocket Pharmaceuticals Inc | 45780V102 | SHS | 300,000 | $1,830,000 | thousands by filing date | call |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 700,000 | $1,666,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 200,000 | $1,548,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 13,000 | $1,304,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 75,000 | $1,139,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 500,000 | $1,050,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 40,000 | $1,021,000 | thousands by filing date | |
| VTV THERAPEUTICS INC CL A | 918385105 | Stock | 200,000 | $966,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 75,000 | $933,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 172,184 | $818,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 46,000 | $734,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 86,100 | $416,000 | thousands by filing date | call |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 20,000 | $376,000 | thousands by filing date | |
| SYNERGY PHARMACEUTICALS DEL | 871639308 | COM NEW | 55,000 | $335,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 46,622 | $328,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-17-000789 | this filing | 2017-02-14 | acceptance time not in the bulk data set |